About this trial
Prospective observational study to evaluate the efficiency of using electrical cardiometry in combination with fecal lipocalin-2 for prediction of NEC in preterm neonates with feeding intolerance
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Chromosomal anomaly or multiple congenital malformations.
Patient with surgical malformation of the intestinal tract (i.e. omphalocele, gastroschisis, malrotation, intestinal atresia)
Patient diagnosed as hypoxic ischemic encephalopathy.
Trial population
Preterm neonates with gestational age ≤ 35 weeks, admitted to NICU, started enteral feeding and diagnosed as having feeding intolerance defined as stage IA and IB by modified bell's staging
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Electrical cardiometry for prediction of NEC in preterm neonates with feeding intolerance
low cardiac output measured by electrical cardiometry predict NEC in preterm with feeding intolerance
Secondary outcomes
Fecal lipocalin-2 for prediction of NEC in preterm neonates with feeding intolerance
High level of lipocalin-2 in stool sample predict NEC in preterm neonates with feeding intolerance
SMA flow in prediction of NEC in preterm neonates with feeding intolerance
low flow through SMA predict NEC in preterm neonates with feeding intolerance
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: